Cadre (CDRE) Competitors

Cadre (NYSE:CDRE) and Enovis (NYSE:ENOV) are both industrial products companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

Does the media prefer CDRE or ENOV?

In the previous week, Cadre and Cadre both had 5 articles in the media. Enovis' average media sentiment score of 0.77 beat Cadre's score of 0.33 indicating that Enovis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cadre	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Enovis	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings and valuation, CDRE or ENOV?

Cadre has higher earnings, but lower revenue than Enovis. Enovis is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cadre	$516.16M	2.55	$38.64M	$0.83	39.07
Enovis	$2.00B	1.25	-$33.26M	-$2.19	-20.45

Is CDRE or ENOV more profitable?

Cadre has a net margin of 6.34% compared to Enovis' net margin of -5.95%. Cadre's return on equity of 12.88% beat Enovis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cadre	6.34%	12.88%	6.06%
Enovis	-5.95%	4.39%	2.80%

Which has more volatility and risk, CDRE or ENOV?

Cadre has a beta of 1.3, indicating that its share price is 30% more volatile than the S&P 500. Comparatively, Enovis has a beta of 1.91, indicating that its share price is 91% more volatile than the S&P 500.

Do analysts prefer CDRE or ENOV?

Cadre currently has a consensus price target of $39.75, suggesting a potential upside of 22.57%. Enovis has a consensus price target of $67.00, suggesting a potential upside of 49.64%. Given Enovis' stronger consensus rating and higher probable upside, analysts clearly believe Enovis is more favorable than Cadre.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cadre	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Enovis	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

Do institutionals and insiders believe in CDRE or ENOV?

44.0% of Cadre shares are owned by institutional investors. Comparatively, 98.4% of Enovis shares are owned by institutional investors. 37.0% of Cadre shares are owned by company insiders. Comparatively, 2.4% of Enovis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Does the MarketBeat Community prefer CDRE or ENOV?

Enovis received 13 more outperform votes than Cadre when rated by MarketBeat users. Likewise, 61.70% of users gave Enovis an outperform vote while only 55.17% of users gave Cadre an outperform vote.

Company	Underperform	Outperform
Cadre	Outperform Votes 16 55.17%	Underperform Votes 13 44.83%
Enovis	Outperform Votes 29 61.70%	Underperform Votes 18 38.30%

Summary

Enovis beats Cadre on 9 of the 17 factors compared between the two stocks.